Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50090-6198

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-6198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Chemical structure diagram of Esomeprazole Magnesium, depicting the molecular composition including magnesium ions and water molecules as part of the compound.*

FDA Label Image

Esmoprazolemagnesiumfigure2 (Esomeprazolemagnesiumfigure2)

A line graph depicting the percentage maintained over a 6-month period for different doses of Esomeprazole Magnesium delayed-release capsules (40 mg, 20 mg, and 10 mg) compared to a placebo. The x-axis represents months from 0 to 6, and the y-axis shows the percent maintained from 0 to 100.*

FDA Label Image

Esmoprazolemagnesiumfigure3 (Esomeprazolemagnesiumfigure3)

A line chart showing the percent maintained over a six-month period for four groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, 10 mg, and placebo. The vertical axis represents percent maintained, and the horizontal axis represents months, indicating the trend in outcomes over time for each dosage and placebo.*

FDA Label Image

Esomeprazolemagnesiumfigure4 (Esomeprazolemagnesiumfigure4)

A line chart showing the percent of patients symptom-free over 28 diary days. It compares three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg (solid circles), 20 mg (solid triangles), and placebo (solid squares). The chart plots symptom-free percentage on the y-axis and diary days on the x-axis, illustrating trends in symptom relief over time for each group.*

FDA Label Image

Esomeprazolemagnesiumfigure5 (Esomeprazolemagnesiumfigure5)

A line graph showing the percentage of patients symptom-free over 28 days of diary tracking. It compares three groups: Esomeprazole Magnesium Delayed-Release Capsules 20 mg, a similar delayed-release formulation also 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis represents the percent of patients symptom-free from 0% to 100%. Both Esomeprazole groups show higher symptom-free percentages over time compared to placebo.*

FDA Label Image

Camber (Camber)

FDA Label Image

Label Image (Lbl500906198)

Label for Esomeprazole Magnesium delayed-release capsules, 20 mg strength, manufactured by A-S Medication Solutions. The label indicates storage instructions to keep at 68 to 77 degrees Fahrenheit and states the package contains 30 capsules. The label includes NDC 50090-6198-0 and lot number details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.